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Abstract. Non-communicable diseases now account for the majority of the global burden of disease and an international
campaign has emerged to raise their priority on the post-2015 development agenda. We argue, to the contrary, that there
remain strong reasons to prioritize maternal and child health. Policy-makers ought to assign highest priority to the health
conditions that afflict the worst off. In virtue of how little healthy life they have had, children who die young are among the
globally worst off. Moreover, many interventions to deal with the conditions that cause mortality in the young are low-cost
and provide great benefits to their recipients. Consistent with the original MillenniumDevelopment Goals, the international
community should continue to prioritize reductions in communicable diseases, neonatal conditions, and maternal health
despite the shifts in the global burden of disease.
THE GROWING BURDEN OF
NON-COMMUNICABLE DISEASE
As the 2015 deadline for the achievement of the Millennium
Development Goals (MDGs) nears, discussion of the next
round of global development priorities is underway. Consider-
able, though uneven, progress has been made toward achieving
each of the health-specific MDGs. Since 1990 it is estimated
that maternal mortality has nearly halved and child mortality
fell from 12.6 million to around 6.6 million in 2012. From 2000
to 2012, estimated global malaria deaths fell to 627,000, a
42% reduction.1
Concomitant with these achievements have come rapid
demographic and population health changes, particularly in
low- and middle-income countries (LMICs). In many LMICs,
life expectancy has increased and populations are aging. The
leading global causes of death and disability have shifted from
communicable diseases affecting children to non-communicable
diseases (NCDs) that predominately affect older adults.2
These changes have prompted international efforts to raise
the priority of NCDs.3 In 2013, the World Health Assembly
unanimously adopted an ambitious plan to reduce premature
deaths from NCDs by 25% by 2025. Near-consensus now exists
that “NCDs should be embedded in the post-2015 development
agenda, since they are leading causes of death and disability.”4
Calls to combat NCDs in LMICs, particularly among the
young and very poor,5 are laudable. Programs for which new
funding can be specifically procured, as well as very low- or
no-cost measures—such as tobacco and alcohol controls—
should be part of the post-2015 agenda.6 Nevertheless, efforts
to elevate the priority of NCDs raise tough questions about
what global health donors should focus on. Resources for
health in LMICs will likely remain scarce. One estimate puts
the annual price tag of investing in “best buy” interventions for
NCDs in LMICs at $11.4 billion USD,7 over one-third of total
global health assistance.8 Meanwhile, despite much progress,
millions of children still die of communicable diseases and
neonatal conditions each year, and hundreds of thousands of
women die of childbirth-related complications.
Given the political fact of resource scarcity, trade-offs are
unavoidable: assigning higher priority to one health goal
diverts resources and attention away from others. Therefore,
international health policy-makers must ask: should the shift in
the burden of disease from communicable diseases to NCDs
prompt a corresponding shift in the priorities of international
health investments? The answer, we argue, is no: the global
community should continue to prioritize maternal and child
health, in large part because these interventions target the
globally worst off.
SETTING PRIORITIES FOR HEALTH SPENDING
Health allocation decisions often use cost-effectiveness
analyses. However, while cost-effectiveness matters, it is not
all that matters. Policy-makers should also take into account
how benefits are distributed within a population.9 In particu-
lar, highest priority should be given to helping the worst off.
Studies of popular preferences suggest that people regard
health improvements of the same size as much more important
when the beneficiaries are worse off. In one study, an improve-
ment that took someone from a disability that left them totally
bedridden to a very severe impairment was rated 28 times as
valuable as an improvement that took someone from a mod-
erate impairment to a slight impairment, even though the
amount of benefit to each individual was regarded as equiva-
lent.10 Similar findings have been widely replicated.11,12 More-
over, the idea that the worst off deserve priority is widely
endorsed in medical ethics and philosophy. Jonathan Wolff
and Avner De-Shalit13 argue that the dominant views in moral
and political philosophy all “converge on the same general
policy prescription in the short to medium term: identify
the worst off and take appropriate steps so that their position
can be improved.”
This convergence suggests the following approach to priority-
setting: health policy-makers should, first, identify the diseases
and conditions that affect the worst off, and, second, imple-
ment the most cost-effective interventions to ameliorate those
conditions. This prompts the question: who are the worst off?
First, being badly off, for the purposes of health priority-
setting, is not simply a matter of one’s health state at a partic-
ular time. The final hours of a dying 20-year old and a dying
80-year old may be equally bad and yet, clearly, the 20-year
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old’s life will have gone worse if she dies. Instead, those who
are worst off are those with the worst overall lives. Individual
episodes of ill health that befall a person matter primarily
because of the negative contribution they make to her overall
life. A concern with how people’s lives go overall best fits with
a number of ethical judgments people make. It explains why
people often think it reasonable to make sacrifices now to
gain benefits in the future. It also explains why someone can
be compensated for a past harm through the provision of
benefits later. And, it explains why people with chronic health
problems are regarded as worse off than those with only
recent ailments, even when their prognoses are the same.
Second, how well a person’s overall life goes is a function of
both the quality and length of her life. Someone’s life is worse
overall if she lives with chronic pain, rather without it. More-
over, her life goes worse if she dies prematurely, rather than
living a full lifetime. That both years of life lost and years lived
in poor health matter is reflected in patients’ everyday judg-
ments, as well as in summary measures of health like quality-
adjusted life-years and disability-adjusted life-years (DALYS).14
If the worst off are those who have the least overall healthy
life, then those who die young will always be among the worst
off. To illustrate, compare someone who dies at age 5 with
someone who dies at age 50. Suppose the 5-year old was in
perfect health until her death. Could the 50-year old be worse
off even though he lived 10 times as long as she did? In order
for them to have had the same amount of valuable life, the
50-year old would have to have spent his life in a state of
illness valued, on average, at 0.9 on the DALY scale (where
perfect health is 0 and death is 1). Only 18 of the 220 health
states for which disability weights are provided have disabil-
ity weights of 0.5 or greater, and none is judged to be nearly
as bad as 0.9.15 This means that no one who lives to age 50
will have had a worse overall life than someone who dies at
age 5. Similar (though less dramatic) results hold for adoles-
cents and young adults: those who die at 15 or 20 years of age
are very likely to be far worse off overall than those who die
in their 50s and older.
Factors other than people’s health conditions can affect how
badly off they are. Economic poverty, poor access to education,
the violation of civil and political rights, and other disadvan-
tages make people worse off. Insofar as these factors are rele-
vant to decisions about health expenditure, they only reinforce
our conclusions, since those who die young are almost all very
disadvantaged in other respects as well. The vast majority of
under-five deaths occur in LMICs and disproportionately
among the poor in these countries.16
Giving priority to the worst off therefore implies that chil-
dren, adolescents, and adults who die young deserve the
highest priority when allocating health resources. The leading
causes of death and disability in younger age groups remain
conditions related to childbirth, nutritional disorders, and
communicable diseases such as lower respiratory infections,
malaria, diarrheal diseases, meningitis, and human immuno-
deficiency virus/acquired immune deficiency syndrome (HIV/
AIDS).17 In contrast, NCDs primarily affect older adults and
the elderly. Only 17% of NCD deaths in LMICs occur among
people under the age of 50.18 Because resources for inter-
national health assistance are scarce, changing spending pri-
orities to focus more on NCDs is likely to divert resources
from the worst off (children) to people who are comparatively
better off (older adults).
Of course, assigning higher priority to the worst off is not
the end of the story. Considerations of cost and benefit are
also relevant to priority-setting decisions. However, these
considerations also support focusing on conditions that affect
those who die young, since many interventions that prevent
death in infants, children, and young adults are cheap and
they confer huge benefits—the opportunity for decades of
worthwhile life that would otherwise have been lost. Many
interventions designed to target communicable diseases and
child mortality, such as vaccinating against common child-
hood diseases, are extremely cost-effective.18 There are also
well-studied, cost-effective measures to treat and prevent dis-
eases such as malaria, HIV/AIDs, diarrheal diseases, nutri-
tional disorders, and to make childbirth safer for mothers
and babies. Conversely, while there are a few highly cost-
effective strategies that target common causes of NCDs, many
interventions for NCDs are considerably more expensive.7
Young people in LMICs die primarily of communicable
conditions, birth-related complications, and nutritional dis-
orders. The health-specific MDGs target these diseases, and
their target reductions will not be achieved by the 2015 dead-
line. Even when the targets are reached, 4 million children
under 5 years of age and over 100,000 women will still
die annually. Further progress on the health-specific MDGs
should remain a priority for the post-2015 development
agenda, even though the global burden of disease has dramat-
ically changed. While the MDG targets need updating, the
high priority given to the conditions that kill the young does
not. Child mortality, communicable diseases, and maternal
mortality ought to remain “at the heart of global health and
development goals.”19
In conclusion, the global health community ought to con-
tinue to focus on maternal and child mortality for three rea-
sons. First, policy-makers should prioritize the worst off and
those who die young are the worst off. Second, interventions to
prevent many of these deaths are low cost. Third, preventing
these diseases confers enormous benefits.
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